Werner Muehelemann
Allon Therapeutics Inc.
NPC-T
COMMENT
May 28, 2008
Main technology is trying to develop a drug for Alzheimer's. Have had good success to now. Still not a commercial product so there is still a lot of risk. Good potential. Has been looking at this one.
are in phase 2 and 3 testing for some drugs. Gotta be willing to be patient on it. Take small positions, be prepared if their testing doesn't work out to loose your money.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.